Blood Components and Pharmacologic Agents in the Treatment of Congenital and Acquired Bleeding Disorders

by Barbara Alving (Editor)

National Heart, Lung, and Blood Institute, Bethesda, MD. Topics include evaluation on patients with abnormal screening studies, point-of-care coagulation instruments, localized bleeding, hemostatic defects in uremia, Von Willebrand disease, treatment choices in hemophilia A and B, and more. For hematologists and oncologists. Softcover.

368 pages, Paperback

First published May 15, 2000